CollPlant Biotechnologies Ltd
CLGN- Exchange
- Nasdaq
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- SEC CIK
- 0001631487
No open-market purchases or sales by CollPlant Biotechnologies Ltd insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $582.4K in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in CollPlant Biotechnologies Ltd as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +1 vs. Q2 2022
- Shares held
- 1.57M
- −166.3K (−9.6%) vs. Q2 2022
- Total value
- $10.7M
- −$3.61M (−25.2%) vs. Q2 2022
- New holders
- 4
- 5 more added
- Sold out
- 3
- 4 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $582.4K |
| Q1 2026 | 21 | $819.0K |
| Q4 2025 | 17 | $1.93M |
| Q3 2025 | 19 | $4.08M |
| Q2 2025 | 18 | $2.53M |
| Q1 2025 | 16 | $3.33M |
| Q4 2024 | 14 | $4.59M |
| Q3 2024 | 13 | $6.79M |
| Q2 2024 | 16 | $7.39M |
| Q1 2024 | 13 | $7.59M |
| Q4 2023 | 17 | $9.14M |
| Q3 2023 | 18 | $8.55M |
| Q2 2023 | 17 | $12.5M |
| Q1 2023 | 18 | $10.9M |
| Q4 2022 | 18 | $13.1M |
| Q3 2022 | 21 | $10.7M |
| Q2 2022 | 20 | $14.3M |
| Q1 2022 | 16 | $19.5M |
| Q4 2021 | 21 | $29.5M |
| Q3 2021 | 15 | $33.1M |
| Q2 2021 | 16 | $51.9M |
| Q1 2021 | 15 | $24.4M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding CollPlant Biotechnologies Ltd; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| First Manhattan Co | 100 | $0 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 173 | $1.00K | 0.00% | +123+246.0% | Added |
| National Bank of Canada | 250 | $2.00K | 0.00% | +250 | New |
| Simplex Trading, LLC | 585 | $3.00K | 0.00% | +585 | New |
| Geneos Wealth Management Inc. | 750 | $5.00K | 0.00% | 00.0% | Unchanged |
| Cohanzick Management, LLC | 2,000 | $14.0K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 3,600 | $24.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 4,800 | $33.0K | 0.00% | +4,800 | New |
| FNY Investment Advisers, LLC | 5,250 | $35.0K | 0.02% | +250+5.0% | Added |
| UBS Group AG | 9,166 | $62.0K | 0.00% | +1,652+22.0% | Added |
| Private Advisor Group, LLC | 12,862 | $87.0K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 13,265 | $90.0K | 0.00% | +13,265 | New |
| Simon Quick Advisors, LLC | 15,676 | $107.0K | 0.02% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 16,382 | $111.0K | 0.01% | 00.0% | Unchanged |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 23,190 | $159.0K | 0.00% | −20−0.1% | Reduced |
| LPL Financial LLC | 28,070 | $191.0K | 0.00% | −17,000−37.7% | Reduced |
| Benjamin F. Edwards & Company, Inc. | 65,410 | $447.0K | 0.02% | −6,400−8.9% | Reduced |
| Brown Advisory Inc | 73,849 | $502.0K | 0.00% | −3,500−4.5% | Reduced |
| Villere St Denis J & Co LLC | 286,197 | $1.95M | 0.15% | +19,300+7.2% | Added |
| Investment Management of Virginia LLC | 403,573 | $2.74M | 0.59% | +57,040+16.5% | Added |
| Roumell Asset Management, LLC | 605,437 | $4.14M | 8.96% | 00.0% | Unchanged |
| ARK Investment Management LLCSuperinvestorARK Invest | 0 | $0 | 0.00% | −235,660−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −892−100.0% | Sold out |
| Venture Visionary Partners LLC | 0 | $0 | 0.00% | −115−100.0% | Sold out |